Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US5045553A · kind A · utility
16Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1988 |
| Grant date | Sep 3, 1991 |
| Priority date | — |
| Expiry date | Jun 17, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition for percutaneous drug absorption which comprises 5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and ethanol and/or an unsaturated higher fatty acid and to a composition of matter which comprises ethanol and/or an unsaturated higher fatty acid and is capable of promoting percutaneous absorption of said dihydropyridine compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.